Article

Study targets E. coli cell wall as culprit in urinary tract infection symptoms

Researchers teasing out the relationship between urinary tract infection and its symptoms are zeroing in on the major component of Escherichia coli's cell wall, lipopolysaccharide (LPS), as the culprit.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
1 expert is featured in this series.
Medcast series
Modern medical office interior with computer and examination table | Image Credit: © New Africa - stock.adobe.com
Urinary bladder | Image Credit: © magicmine - stock.adobe.com
Related Content
Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration
January 18th 2025

Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration

Mark T. Edney, MD
"There are far more people presenting to us for care than we have people able to provide it. The APPs are going to be a critical part of trying to solve that puzzle," says Mark T. Edney, MD.
Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges
January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD
Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.
Illuccix approved in Europe for detection of PSMA-positive lesions
January 17th 2025

Illuccix approved in Europe for detection of PSMA-positive lesions

Hannah Clarke
The European approval of Illuccix adds on to prior approvals in the US, Australia, and Canada.
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
Addition of PSMA PET led to notable stage migration in mHSPC, study shows
January 16th 2025

Addition of PSMA PET led to notable stage migration in mHSPC, study shows

Hannah Clarke
In total, 40.3% of patients experienced a change in staging between initial assessment on conventional imaging and PSMA PET.
Anktiva targets expanded indication in US and global approvals in EU and UK
January 16th 2025

Anktiva targets expanded indication in US and global approvals in EU and UK

Hannah Clarke
The planned sBLA will seek approval of Anktiva for patients with BCG-unresponsive NMIBC in the papillary indication.
© 2025 MJH Life Sciences

All rights reserved.